Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform. Its lead product candidate is KP1077, consisting of KP1077IH, which is...
34 insider purchases on record · latest filing 2025-09-16.
Insiders have also filed 19 sale transactions at ZVRA.